Researchers are also investigating the PD-1 immune checkpoint inhibitor as treatment before surgical and radiation treatment.

Key Words: epidemiology, oral squamous cell carcinoma, human papillomavirus. Oral cancer includes cancer of the lip and oral cavity ( buccal mucosa, gingiva, hard palate, tongue and floor of mouth) (1 ...

FITOPROT, which contains curcuminoids and Bidens pilosa L. extract, is an innovative mucoadhesive formulation indicated for the topical treatment of chemoradiotherapy-induced oral mucositis (OM) in ...

aState Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou 510060, China bGuangdong Esophageal Cancer ...

What is squamous cell carcinoma? Also called squamous cell skin cancer, this is a common type of skin cancer. It tends to develop in people who have had lots of sun exposure, use(d) tanning beds, or ...

Chile Oral Squamous Cell Carcinoma (OSCC), the main form of oral cancer, is a major health problem globally that affects 400,000 people every year. It has been postulated that periodontitis, a chronic ...

The American Academy of Dermatology gratefully acknowledges the support from Regeneron. What causes squamous cell skin cancer? People usually develop this skin cancer because ultraviolet (UV) light ...

Surgery is the go-to treatment for cutaneous squamous cell carcinoma (CSCC) — a type of cancer that develops in the squamous cells of the skin. But there are other ways to treat the cancer if a ...

Abstract: Oral cancer is a major global health issue accounting for 177,384 deaths in 2018 and it is most prevalent in low- and middle-income countries. Enabling automation in the identification of ...

Background: To assess the oncologic outcomes in patients with oral squamous cell carcinoma (SCC) who underwent treatment with radiotherapy (RT) or chemoradiation therapy (CRT) following neoadjuvant ...

Department of Ultrasound, Ninth People’s Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200001, P.R. China ...

While CAR T cell therapy—a personalized form of cancer immunotherapy first successfully developed by Carl June, MD, and his team at Penn—has revolutionized treatment for many blood cancers ...